Arkadios Wealth Advisors Gsk PLC Transaction History

Arkadios Wealth Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 14, 2022	SELL	$42.05 - $47.77 $420 - $477	-10 Reduced 0.01%	72,930 $3.18 Million
Q1 2022 May 02, 2022	BUY	$40.23 - $47.74 $681,214 - $808,381	16,933 Added 30.23%	72,940 $3.18 Million
Q4 2021 Feb 03, 2022	SELL	$38.88 - $45.31 $34,564 - $40,280	-889 Reduced 1.56%	56,007 $2.47 Million
Q3 2021 Oct 19, 2021	BUY	$38.79 - $43.16 $78,704 - $87,571	2,029 Added 3.7%	56,896 $2.17 Million
Q2 2021 Jul 28, 2021	BUY	$36.52 - $41.46 $1.88 Million - $2.14 Million	51,612 Added 1585.62%	54,867 $2.18 Million
Q1 2021 Apr 26, 2021	BUY	$34.27 - $40.01 $9,150 - $10,682	267 Added 8.94%	3,255 $116,000
Q4 2020 Feb 09, 2021	BUY	$34.07 - $39.94 $101,801 - $119,340	2,988 New	2,988 $109,000
Q2 2020 Aug 10, 2020	SELL	$37.87 - $43.58 $19,768 - $22,748	-522 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $21,924 - $25,186	522 New	522 $25,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.